A minimally invasive genetic test that allows to study the genetic evolution of the tumor from circulating free nucleic acids (cfTNA) and circulating tumor cells (CTCs), combined with the analysis with new generation massive sequencing (NGS). The information obtained enables the creation of a dynamic tumor control report. DECODER analyzes 90 distinct genes, including SNVs, CNVs, Gene fusions and Tumor suppressor genes.
Provides accurate information in real time about the genetic profile of the tumor and the prognosis after treatment.
The enumeration of CTCs is an effective biomarker and allows to monitor the efficacy of adjuvant therapies.
Allows early detection of metastases, before standard methods.